|

Boeing, J&J Shares Flout Good Sense

A glance at the charts of Boeing and Johnson & Johnson shows what stock-market bears are up against as they patiently await a meaningful correction of excesses that have been building in the financial system for nearly a decade.  Are the portfolio managers who support these two stocks without a trace of nervousness crazy, or what? Boeing has received relentlessly negative press since December, and for good reason. Its huge fleet of 737 Max jets has been grounded for an overhaul of faulty navigation equipment that caused two crashes resulting in 346 deaths and a spate of lawsuits around the world. For its part, Johnson & Johnson just got socked with an $8 billion jury award that is not even related to the motherlode of lawsuits they will face because of talcum powder’s supposedly carcinogenic effects. The $8 billion verdict involved a guy who supposedly developed man-boobs after taking J&J’s antipsychotic drug Risperdal as a child. Boeing may be in slightly better shape, having made progress settling with the families of some of the passengers who died in the crashes. But other aggrieved families undoubtedly will seek jury trials that will leave the airline exposed to open-ended liabilities for the foreseeable future

Portfolio Omerta

And yet, the charts show that the shares of both companies have held up astoundingly well considering that their legal problems could drag on for years or even decades. After shaking out the weak hands, DaBoyz put the stocks back on their respective glide paths as though nothing of consequence had happened. Indeed, the stocks look capable of remaining buoyant more or less indefinitely, or at least until the inevitable bear market lays waste to all stocks. In the meantime, the omerta that binds those who make their living throwing Other People’s Money at a small handful of must-own stocks will prevail. A stampede out of Boeing and Johnson & Johnson shares in particular is coming, but not until a bull market that long ago took leave of its senses draws its last breath.

Author

Rick Ackerman

Rick Ackerman

Rick’s Picks

Barron’s once labeled Rick Ackerman an “intrepid trader” in a headline that alluded to his key role in solving a notorious pill-tampering case.

More from Rick Ackerman
Share:

Editor's Picks

EUR/USD treads water around 1.1900

EUR/USD edges a tad lower around the 1.1900 area, coming under mild pressure despite the US Dollar keeps the offered stance on turnaround Tuesday. On the US data front, December Retail Sales fell short of expectations, while the ADP four week average printed at 6.5K.

GBP/USD looks weak near 1.3670

GBP/USD trades on the back foot around the 1.3670 region on Tuesday. Cable’s modest retracement also comes in tandem with the decent decline in the Greenback. Moving forward, the US NFP and CPI data in combination with key UK releases should kee the quid under scrutiny in the next few days.

Gold the battle of wills continues with bulls not ready to give up

Gold comes under marked selling pressure on Tuesday, giving back part of its recent two day advance and threatening to challenge the key $5,000 mark per troy ounce. The yellow metal’s correction follows a better tone in the risk complex, a lower Greenback and shrinking US Treasuty yields.

AI Crypto Update: BankrCoin, Pippin surge as sector market cap steadies above $12B

The Artificial Intelligence (AI) segment is largely on the back foot with major coins such as Bittensor (TAO) and Internet Computer (ICP) extending losses amid a sticky risk-off sentiment.

Dollar drops and stocks rally: The week of reckoning for US economic data

Following a sizeable move lower in US technology Stocks last week, we have witnessed a meaningful recovery unfold. The USD Index is in a concerning position; the monthly price continues to hold the south channel support.

XRP holds $1.40 amid ETF inflows and stable derivatives market

Ripple trades under pressure, with immediate support at $1.40 holding at the time of writing on Tuesday. A recovery attempt from last week’s sell-off to $1.12 stalled at $1.54 on Friday, leading to limited price action between the current support and the resistance.